Search results

Page title matches

• Imipenem-relebactam
  *Also includes cilastatin, as per usual with imipenem
  432 bytes (49 words) - 10:02, 26 August 2020

Page text matches

• MexXY-OprM efflux pump
  ...in]], [[sulbenicillin]], [[cefsulodin]], [[ceftazidime]], [[oxacephem]], [[imipenem]], and [[aztreonam]])
  454 bytes (39 words) - 09:35, 15 September 2020
• Antipseudomonal antibiotics
  *** [[Imipenem]]
  683 bytes (45 words) - 22:47, 7 February 2022
• Multidrug-resistant Gram-negative bacteria
  *[[Imipenem-relebactam]] (really imipenem-cilastatin-relebactam): still awaiting Health Canada Drug Review
  1 KB (159 words) - 17:18, 2 October 2022
• Pseudomonas aeruginosa
  **Decreased or absent OprD porin: resistance to [[carbapenems]] ([[imipenem]] and [[meropenem]]) that may spare other β-lactams ...AB-OprM: resistance to [[fluoroquinolones]] and all [[β-lactams]] except [[imipenem]]
  4 KB (479 words) - 11:35, 11 July 2023
• Ochrobactrum anthropi
  * Susceptible to gentamicin, amikacin, imipenem, ceftriaxone, and cefoperazone
  450 bytes (43 words) - 08:37, 19 January 2021
• Lactobacillus
  ** However, one study noted susceptibility to [[imipenem]], [[piperacillin-tazobactam]], [[erythromycin]], and [[clindamycin]], but
  548 bytes (57 words) - 09:05, 4 August 2022
• Morganellaceae
  *Intrinsic reduced susceptibility to [[imipenem]]
  648 bytes (70 words) - 11:19, 8 October 2020
• Imipenem-relebactam
  *Also includes cilastatin, as per usual with imipenem
  432 bytes (49 words) - 10:02, 26 August 2020
• Burkholderia mallei
  *Treatment is with [[Is treated by::ceftazidime]], [[Is treated by::imipenem]], [[Is treated by::doxycycline]], or [[Is treated by::TMP-SMX]]
  490 bytes (51 words) - 08:20, 14 October 2020
• Acinetobacter lwoffii
  * [[Meropenem]] and [[imipenem]] are reliable, as are [[fluoroquinolones]], [[aminoglycosides]], [[minocyc
  699 bytes (66 words) - 07:08, 20 March 2024
• Mycobacterium abscessus
  ** [[Imipenem]] 1 g IV q12h or [[cefoxitin]] 8-12 g/day in 2-3 divided doses for 2 weeks,
  586 bytes (75 words) - 06:30, 14 August 2020
• Carbapenem-resistant organisms
  |[[imipenem-relebactam]] ...enemase) consider: [[ceftazidime-avibactam]], [[meropenem-vaborbactam]], [[imipenem-relebactam]], [[cefiderocol]]
  7 KB (848 words) - 08:58, 30 August 2022
• Antibiotics in sodium restriction
  | [[Imipenem]] || 1.71
  1 KB (117 words) - 21:15, 20 December 2019
• Delftia acidovorans
  ...reated with [[piperacillin-tazobactam]], [[meropenem]], [[ceftazidime]], [[imipenem]], [[aminoglycosides]], and [[fluoroquinolones]]
  1 KB (111 words) - 08:59, 26 May 2021
• Alcaligenes faecalis
  * Most reliable antibiotics are [[imipenem]], [[meropenem]], and [[ceftazidime]] (about 66% susceptible), followed by
  1 KB (124 words) - 12:35, 16 January 2023
• Nutritionally variant streptococci
  |Imipenem
  1 KB (109 words) - 15:28, 11 March 2022
• Intrinsic antibiotic resistance
  ![[Imipenem|IMI]] *The [[Morganellaceae]] may have elevated MICs to [[imipenem]], but should be reported as susceptible if susceptible in vitro
  5 KB (614 words) - 11:28, 18 February 2022
• Urinary tract infection
  ** Preferred: [[ertapenem]], [[meropenem]], [[imipenem-cilastatin]], [[ciprofloxacin]], [[levofloxacin]], or [[trimethoprim-sulfam ...(if susceptible), [[ceftazidime-avibactam]], [[meropenem-vaborbactam]], [[imipenem-cilastatin-relebactam]], [[cefiderocol]]
  4 KB (458 words) - 08:55, 30 August 2022
• Multidrug-resistant organism
  |[[imipenem]], [[meropenem]], [[doripenem]] |[[ertapenem]], [[imipenem]], [[meropenem]], [[doripenem]]
  7 KB (668 words) - 17:10, 2 October 2022
• Burkholderia cepacia complex
  ** [[Meropenem]] 1-2 g IV q8h and [[imipenem]] 1 g IV q8h
  1 KB (156 words) - 12:48, 6 February 2023
• AmpC β-lactamase
  **Also [[imipenem]], though it remains effective even after induction of AmpC overexpression
  2 KB (192 words) - 16:17, 24 November 2021
• Antibiotic spectrum index
  ...Cefiderocol]], [[Colistin]], [[Polymyxin B]], [[Meropenem-vaborbactam]], [[Imipenem-relebactam]], [[Ceftazidime-avibactam]], [[Ceftolozane-tazobactam]], [[Tige |[[Imipenem-cilastatin]]
  6 KB (341 words) - 14:34, 4 April 2024
• Chromobacterium violaceum
  *[[Fluoroquinolones]], [[chloramphenicol]], [[tetracyline]], [[TMP-SMX]], [[imipenem]], [[gentamicin]]
  2 KB (167 words) - 22:48, 7 February 2022
• Tissue penetration of antimicrobials
  |[[imipenem]] |imipenem
  16 KB (1,586 words) - 10:55, 1 November 2023
• Achromobacter
  ...are [[TMP-SMX]], [[ceftazidime]], [[piperacillin]], and [[carbapenems]] ([[imipenem]] more than [[meropenem]])
  2 KB (225 words) - 11:03, 17 November 2022
• Drug-induced vasculitis
  ...t: [[ofloxacin]], [[ciprofloxacin]], [[lomefloxacin]], [[tetracycline]], [[imipenem/cilastatin]], [[cefaclor]], [[cefuroxime]], [[vancomycin]], [[teicoplanin]]
  2 KB (203 words) - 21:52, 20 July 2020
• Ganciclovir
  * [[Zidovudine]], [[didanosine]], [[probenecid]], and [[imipenem-cilastatin]] (increases risk of seizures)
  1 KB (170 words) - 14:44, 9 January 2024
• Capnocytophaga canimorsus
  * Highly susceptible to [[meropenem]], [[imipenem]], [[piperacillin-tazobactam]], [[amoxicillin-clavulanic acid]], and [[tige
  2 KB (195 words) - 22:44, 26 September 2022
• Carbapenemases
  **'''IMI-1''' (imipenem-hydrolyzing β-lactamase) is chromasomal and found in [[Enterobacter cloaca **'''IMP''' (active on imipenem) is on a conjugative plasmid and is mostly found in [[Pseudomonas aeruginos
  4 KB (568 words) - 12:44, 25 January 2022
• Roseomonas
  * Generally susceptible to [[aminoglycosides]], [[tetracycline]], and [[imipenem]]
  2 KB (210 words) - 21:33, 5 July 2022
• Enterococcus
  ...ertapenem]], but ampicillin-susceptible strains are often susceptible to [[imipenem]] and (less reliably) to [[meropenem]]
  2 KB (277 words) - 12:06, 7 November 2022
• Diabetic foot infection
  |[[imipenem-cilastatin]]
  3 KB (321 words) - 00:02, 28 January 2022
• Antimicrobial abbreviations
  | [[imipenem]] || IPM | [[imipenem-relebactam]] || I-R
  7 KB (760 words) - 10:12, 13 October 2019
• Campylobacter
  ** Options include [[ampicillin]], [[imipenem]], [[chloramphenicol]], [[gentamicin]], [[fluoroquinolones]] if not resista
  3 KB (347 words) - 10:54, 18 February 2022
• Rhodococcus hoagii
  ...ion of [[macrolide]] or [[fluoroquinolone]] plus two of: [[vancomycin]], [[imipenem]], [[linezolid]], or an [[aminoglycoside]]
  3 KB (357 words) - 12:49, 31 August 2022
• Drug-resistant tuberculosis
  ...]], [[pyrazinamide]], [[delamanid]], [[amikacin]] (or [[streptomycin]]), [[imipenem-cilastatin]] (or [[meropenem)]], [[ethionamide]], [[p-aminosalicylic acid]]
  4 KB (525 words) - 21:48, 1 April 2023
• Dosing of antimicrobials in obesity
  | [[Imipenem]]
  5 KB (683 words) - 12:36, 8 June 2023
• Nocardia
  ...by::TMP-SMX]] plus either [[Is treated by::amikacin]] or [[Is treated by::imipenem]]
  4 KB (534 words) - 18:05, 12 March 2023
• Burkholderia pseudomallei
  **Induction: [[Is treated by::ceftazidime]], [[Is treated by::imipenem]], or [[Is treated by::meropenem]] for 10-14 days
  4 KB (495 words) - 09:36, 25 May 2021
• Outpatient Parenteral Antimicrobial Therapy (OPAT) (IDSA 2018)
  |Imipenem
  10 KB (1,132 words) - 14:01, 9 February 2023
• Outpatient Parenteral Antimicrobial Therapy (OPAT) (IDSA 2004)
  | Imipenem-cilastatin
  8 KB (953 words) - 11:31, 11 January 2023
• Skin and soft tissue infections (SSTI) (IDSA 2014)
  * Treated with ceftazidime, gentamicin, imipenem, doxycycline, or ciprofloxacin for a prolonged course (?6 months)
  19 KB (2,503 words) - 22:20, 16 June 2020